Opioid Resource Center
FDA/CDC
FDA to expand opioid labeling with instructions on proper tapering
The label changes are intended to be used when both the clinician and patient have agreed to reduce the opioid dosage.
Conference Coverage
NIH’s HEAL initiative seeks coordinated effort to tackle pain, addiction
MILWAUKEE – The two aims of research under the initiative are to improve treatments for misuse and addiction, and to enhance pain management.
Feature
Report calls for focus on ‘subpopulations’ to fight opioid epidemic
“Methadone, buprenorphine, and extended-release naltrexone ... save lives” but most people with OUD get no treatment, new report says.
Conference Coverage
Opioid overdose risk greater among HIV patients
From the Journals
Teens likely to mimic parents’ opioid use
Interventions that target parental use and emphasize positive parenting may lower adolescent opioid use.
From the Journals
In California, opioids most often prescribed in low-income, mostly white areas
Opioid-related overdose deaths are highest in low-income white areas.
From the Journals
Residential HCV program improves veterans’ diagnosis and care
From the Journals
Buprenorphine for NAS shows promise in reducing length of stay
Up to 70% of newborns with NAS will require pharmacologic treatment to alleviate symptoms.
News from the FDA/CDC
FDA labeling templates smooth way for OTC naloxone
The templates aim to ease the submission process for manufacturers.
MDedge Psychcast
Rural suicidality and resilience
Addressing suicide in rural communities presents unique challenges.
From the Journals
App aims to detect respiratory failure in opioid overdoses
If a disordered breathing pattern is detected, the app is designed to send a text message to a prespecified contact.